FDA issues manufacturing guidance for pharmaceutical manufacturers
Consumers spend too much on pharmaceuticals and the FDA is attempting to ease that burden. The FDA recently issued its final guidance in a set of formalized practices to ensure the quality of pharmaceuticals in manufacturing. Although drug companies try to circumvent FDA regulations, this guidance strengthens the FDA’s requirements for ensuring manufacturing quality. The guidance also aims to improve efficiency, which should help lower costs for consumers and prevent shortages of medicine due to manufacturing failures.
Bookmark: 
